Transplantation Osteoporosis

Osteoporosis in Men

Volumn , Issue , 2010, Pages 443-452

  Stein, Emily M ^a   Compston, Juliet ^b   Shane, Elizabeth ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80655148354     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374602-3.00037-7     Document Type: Chapter

References (90)

1. Cohen A., Ebeling P., Sprague S., Shane E. Transplantation osteoporosis. Primer on the Metabolic Bone Diseases and Disorders of Bone and Mineral Metabolism 2006, 302-309. American Society for Bone and Mineral Research., Washington DC. M. Favus (Ed.).
2. Cohen A., Shane E. Osteoporosis after solid organ and bone marrow transplantation. Osteoporos. Int. 2003, 14:617-630.
3. Epstein S., Shane E. Transplantation osteoporosis. Osteoporosis 2001, 327-340. Academic Press, San Diego. R. Marcus, D. Feldman, J. Kelsey (Eds.).
4. Maalouf N.M., Shane E. Osteoporosis after solid organ transplantation. J. Clin. Endocrinol. Metab. 2005, 90:2456-2465.
5. Stein E., Shane E. Transplantation osteoporosis. Osteoporosis, Pathophysiology and Clinical Management 2009, 567-602. Humana Press, Totowana NJ. R. Adler (Ed.).
6. Mazziotti G., Angeli A., Bilezikian J.P., Canalis E., Giustina A. Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol. Metab. 2006, 17:144-149.
7. Sambrook P. Glucocorticoid-induced osteoporosis. Primer on the Metabolic Bone Diseases and other Disorders of Bone and Mineral Metabolism 2006, 296-302. American Society for Bone and Mineral Research, Washington DC. M. Favus (Ed.).
8. van Staa T.P. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis. Calcif. Tissue Int. 2006, 79:129-137.
9. Mikuls T.R., Julian B.A., Bartolucci A., Saag K.G. Bone mineral density changes within six months of renal transplantation. Transplantation 2003, 75:49-54.
10. Ninkovic M., Love S., Tom B.D., Bearcroft P.W., Alexander G.J., Compston J.E. Lack of effect of intravenous pamidronate on fracture incidence and bone mineral density after orthotopic liver transplantation. J. Hepatol. 2002, 37:93-100.
11. Shane E., Addesso V., Namerow P.B., et al. Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. N. Engl. J. Med. 2004, 350:767-776.
12. Wissing K.M., Broeders N., Moreno-Reyes R., Gervy C., Stallenberg B., Abramowicz D. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 2005, 79:108-115.
13. Opelz G., Dohler B., Laux G. Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients. Am. J. Transplant. 2005, 5:720-728.
14. van den Ham E.C., Kooman J.P., Christiaans M.L., van Hooff J.P. The influence of early steroid withdrawal on body composition and bone mineral density in renal transplantation patients. Transpl. Int. 2003, 16:82-87.
15. Kahan B.D. Cyclosporine. N. Engl. J. Med. 1989, 321:1725-1738.
16. Tamler R., Epstein S. Nonsteroid immune modulators and bone disease. Ann. NY Acad. Sci. 2006, 1068:284-296.
17. Ponticelli C., Aroldi A. Osteoporosis after organ transplantation. Lancet 2001, 357:1623.
18. Grotz W.H., Mundinger A., Gugel B., Exner V., Kirste G., Schollmeyer P.J. Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplant. 1994, 58:912-915.
19. McIntyre H.D., Menzies B., Rigby R., Perry-Keene D.A., Hawley C.M., Hardie I.R. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens. Clin. Transplant. 1995, 9:20-24.
20. Cueto-Manzano A.M., Konel S., Crowley V., et al. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients. Transplantation 2003, 75:2053-2058.
21. Josephson M.A., Schumm L.P., Chiu M.Y., Marshall C., Thistlethwaite J.R., Sprague S.M. Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation 2004, 78:1233-1236.
22. Cvetkovic M., Mann G.N., Romero D.F., et al. The deleterious effects of long term cyclosporin A, cyclosporin G and FK506 on bone mineral metabolism in vivo. Transplantation 1994, 57:1231-1237.
23. Stempfle H.U., Werner C., Echtler S., et al. Rapid trabecular bone loss after cardiac transplantation using FK506 (tacrolimus)-based immunosuppression. Transplant. Proc. 1998, 30:1132-1133.
24. Park K.M., Hay J.E., Lee S.G., et al. Bone loss after orthotopic liver transplantation: FK 506 versus cyclosporine. Transplant. Proc. 1996, 28:1738-1740.
25. Goffin E., Devogelaer J.P., Lalaoui A., et al. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transpl. Int. 2002, 15:73-80.
26. Monegal A., Navasa M., Guanabens N., et al. Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif. Tissue Int. 2001, 68:83-86.
27. Dissanayake I.R., Goodman G.R., Bowman A.R., et al. Mycophenolate mofetil; a promising new immunosuppressant that does not cause bone loss in the rat. Transplantation 1998, 65:275-278.
28. K. Martin, Z. Al-Aly, E. Gonzalez, Renal osteodystrophy, in: M. Favus (Ed.), Primer on the Metabolic Bone Diseases and other Disorders of Bone and Mineral Metabolism, 2006, pp. 359-366.
29. Coco M., Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 2000, 36:1115-1121.
30. Nickolas T.L., McMahon D.J., Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J. Am. Soc. Nephrol. 2006, 17:3223-3232.
31. Ahn H.J., Kim H.J., Kim Y.S., et al. Risk factors for changes in bone mineral density and the effect of antiosteoporosis management after renal transplantation. Transplant. Proc. 2006, 38:2074-2076.
32. Julian B.A., Laskow D.A., Dubovsky J., Dubovsky E.V., Curtis J.J., Quarrles L.D. Rapid, loss of vertebral bone density after renal transplantation. N. Engl. J. Med. 1991, 325:544-550.
33. Almond M.K., Kwan J.T.C., Evans K., Cunningham J. Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 1994, 66:52-57.
34. Roe S.D., Porter C.J., Godber I.M., Hosking D.J., Cassidy M.J. Reduced bone mineral density in male renal transplant recipients: evidence for persisting hyperparathyroidism. Osteoporos. Int. 2005, 16:142-148.
35. Ramsey-Goldman R., Dunn J.E., Dunlop D.D., et al. Increased risk of fracture in patients receiving solid organ transplants. J. Bone Miner. Res. 1999, 14:456-463.
36. Ball A.M., Gillen D.L., Sherrard D., et al. Risk of hip fracture among dialysis and renal transplant recipients. J. Am. Med. Assoc. 2002, 288:3014-3018.
37. Smets Y.F., de Fijter J.W., Ringers J., Lemkes H.H., Hamdy N.A. Long-term follow-up study on bone mineral density and fractures after simultaneous pancreas-kidney transplantation. Kidney Int. 2004, 66:2070-2076.
38. Monier-Faugere M., Mawad H., Qi Q., Friedler R., Malluche H.H. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J. Am. Soc. Nephrol. 2000, 11:1093-1099.
39. Akaberi S., Lindergard B., Simonsen O., Nyberg G. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Transplantation 2006, 82:749-752.
40. Cohen A., Shane E. Bone disease in patients before and after cardiac transplantation. Bone Disease of Organ Transplantation 2005, 287-301. Elsevier Academic Press, Burlington. J.E. Compston, E. Shane (Eds.).
41. Sambrook P.N., Kelly P.J., Keogh A., et al. Bone loss after cardiac transplantation: a prospective study. J. Heart Lung Transplant. 1994, 13:116-121.
42. Shane E., Rivas M., McMahon D.J., et al. Bone loss and turnover after cardiac transplantation. J. Clin. Endocrinol. Metab. 1997, 82:1497-1506.
43. Shane E., Rivas M., Staron R.B., et al. Fracture after cardiac transplantation: a prospective longitudinal study. J. Clin. Endocrinol. Metab. 1996, 81:1740-1746.
44. Leidig-Bruckner G., Hosch S., Dodidou P., et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001, 357:342-347.
45. Kerschan-Schindl K., Ruzicka M., Mahr S., et al. Unexpected low incidence of vertebral fractures in heart transplant recipients: analysis of bone turnover. Transpl. Int. 2008, 21:255-262.
46. Sambrook P.N., Kelly P.J., Fontana D., et al. Mechanisms of rapid bone loss following cardiac transplantation. Osteoporos. Int. 1994, 4:273-276.
47. Fleischer J., McMahon D.J., Hembree W., Addesso V., Longcope C., Shane E. Serum testosterone levels after cardiac transplantation. Transplantation 2008, 85:834-839.
48. Ninkovic M., Love S.A., Tom B., Alexander G.J., Compston J.E. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif. Tissue Int. 2001, 69:321-326.
49. Crosbie O.M., Freaney R., McKenna M.J., Hegarty J.E. Bone density, vitamin D status, and disordered bone remodeling in end- stage chronic liver disease. Calcif. Tissue Int. 1999, 64:295-300.
50. Compston J.E. Osteoporosis after liver transplantation. Liver Transpl. 2003, 9:321-330.
51. Guichelaar M.M., Kendall R., Malinchoc M., Hay J.E. Bone mineral density before and after OLT: long-term follow-up and predictive factors. Liver Transpl. 2006, 12:1390-1402.
52. Eastell R., Dickson R.E., Hodgson S.F., et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991, 14:296-300.
53. Floreani A., Mega A., Tizian L., et al. Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study. Osteoporos. Int. 2001, 12:749-754.
54. Monegal A., Navasa M., Guanabens N., et al. Bone disease after liver transplantation: a long-term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporos. Int. 2001, 12:484-492.
55. Ninkovic M., Skingle S.J., Bearcroft P.W., Bishop N., Alexander G.J., Compston J.E. Incidence of vertebral fractures in the first three months after orthotopic liver transplantation. Eur. J. Gastroenterol. Hepatol. 2000, 12:931-935.
56. de Kroon L., Drent G., van den Berg A.P., Haagsma E.B. Current health status of patients who have survived for more than 15 years after liver transplantation. Neth. J. Med. 2007, 65:252-258.
57. Vedi J., Greer S., Skingle S., et al. Mechanism of bone loss after liver transplantation: a histomorphometric analysis. J. Bone Miner. Res. 1999, 14:281-287.
58. Shane E., Silverberg S.J., Donovan D., et al. Osteoporosis in lung transplantation candidates with end stage pulmonary disease. Am. J. Med. 1996, 101:262-269.
59. Aris R.M., Renner J.B., Winders A.D., et al. Increased rate of fractures and severe kyphosis: sequelae of living into adulthood with cystic fibrosis. Ann. Intern. Med. 1998, 128:186-193.
60. Elkin S.L., Fairney A., Burnett S., et al. Vertebral deformities and low bone mineral density in adults with cystic fibrosis. Osteoporos. Int. 2001, 12:366-372.
61. Ferrari S.L., Nicod L.P., Hamacher J., et al. Osteoporosis in patients undergoing lung transplantation. Eur. Respir. J. 1996, 9:2378-2382.
62. Shane E., Papadopoulos A., Staron R.B., et al. Bone loss and fracture after lung transplantation. Transplantation 1999, 68:220-227.
63. Ebeling P., Thomas D., Erbas B., Hopper L., Szer J., Grigg A. Mechanism of bone loss following allogeneic and autologous hematopoeitic stem cell transplantation. J. Bone Miner. Res. 1999, 14:342-350.
64. Gandhi M.K., Lekamwasam S., Inman I., et al. Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: long-term follow-up of a prospective study. Br. J. Haematol. 2003, 121:462-468.
65. Fan S., Almond M.K., Ball E., Evans K., Cunningham J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int. 2000, 57:684-690.
66. Coco M., Glicklich D., Faugere M.C., et al. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J. Am. Soc. Nephrol. 2003, 14:2669-2676.
67. Bianda T., Linka A., Junga G., et al. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif. Tissue Int. 2000, 67:116-121.
68. Krieg M., Seydoux C., Sandini L., et al. Intravenous pamidronate as a treatment for osteoporosis after heart transplantation: a prospective study. Osteoporos. Int. 2001, 12:112-116.
69. Pennisi P., Trombetti A., Giostra E., Mentha G., Rizzoli R., Fiore C.E. Pamidronate and osteoporosis prevention in liver transplant recipients. Rheumatol. Int. 2007, 27:251-256.
70. Aris R.M., Lester G.E., Renner J.B., et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. Am. J. Respir Crit. Care Med. 2000, 162:941-946.
71. Trombetti A., Gerbase M.W., Spiliopoulos A., Slosman D.O., Nicod L.P., Rizzoli R. Bone mineral density in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss by pamidronate. J. Heart Lung Transplant. 2000, 19:736-743.
72. Kananen K., Volin L., Laitinen K., Alfthan H., Ruutu T., Valimaki M.J. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J. Clin. Endocrinol. Metab. 2005, 90:3877-3885.
73. Grigg A.C., Shuttleworth P., Reynolds J., et al. Pamidronate therapy for one year after allogeneic bone marrow transplantation (AlloBMT) reduces bone loss from the lumbar spine, femoral neck and total hip. Blood 2004, 104:A2253.
74. Hommann M., Abendroth K., Lehmann G., et al. Effect of transplantation on bone: osteoporosis after liver and multivisceral transplantation. Transplant. Proc. 2002, 34:2296-2298.
75. Crawford B.A., Kam C., Pavlovic J., et al. Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 2006, 144:239-248.
76. Grotz W., Nagel C., Poeschel D., et al. Effect of ibandronate on bone loss and renal function after kidney transplantation. J. Am. Soc. Nephrol. 2001, 12:1530-1537.
77. Haas M., Leko-Mohr Z., Roschger P., et al. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int. 2003, 63:1130-1136.
78. Tauchmanova L., Ricci P., Serio B., et al. Short-term zoledronic acid treatment increases bone mineral density and marrow clonogenic fibroblast progenitors after allogeneic stem cell transplantation. J. Clin. Endocrinol. Metab. 2005, 90:627-634.
79. Nowacka-Cieciura E., Cieciura T., Baczkowska T., et al. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transplant. Proc. 2006, 38:165-167.
80. Torregrosa J.V., Fuster D., Pedroso S., et al. Weekly risedronate in kidney transplant patients with osteopenia. Transpl. Int. 2007, 20:708-711.
81. Toro J., Gentil M.A., Garcia R., et al. Alendronate in kidney transplant patients: a single-center experience. Transplant. Proc. 2005, 37:1471-1472.
82. Atamaz F., Hepguler S., Karasu Z., Kilic M., Tokat Y. The prevention of bone fractures after liver transplantation: experience with alendronate treatment. Transplant. Proc. 2006, 38:1448-1452.
83. Al-Gabri S., Zadrazil J., Krejci K., Horak P., Bachleda P. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation. Transplant. Proc. 2005, 37:1014-1019.
84. Cohen A., Sambrook P., Shane E. Management of bone loss after organ transplantation. J. Bone Miner. Res. 2004, 19:1919-1932.
85. El-Agroudy A.E., El-Husseini A.A., El-Sayed M., Ghoneim M.A. Preventing bone loss in renal transplant recipients with vitamin D. J. Am. Soc. Nephrol. 2003, 14:2975-2979.
86. Sambrook P., Henderson N.K., Keogh A., et al. Effect of calcitriol on bone loss after cardiac or lung transplantation. J. Bone Miner. Res. 2000, 15:1818-1824.
87. Henderson K., Eisman J., Keogh A., et al. Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J. Bone Miner. Res. 2001, 16:565-571.
88. Cueto-Manzano A.M., Konel S., Freemont A.J., et al. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am. J. Kidney Dis. 2000, 35:227-236.
89. Stempfle H.U., Werner C., Siebert U., et al. The role of tacrolimus (FK506)-base immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 2002, 73:547-552.
90. Fahrleitner A., Prenner G., Tscheliessnigg K.H., et al. Testosterone supplementation has additional benefits on bone metabolism in cardiac transplant recipients receiving intravenous bisphosphonate treatment: a prospective study. J. Bone Miner. Res. 2002, 17:S388.